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Abstract 
Raman Spectroscopy Detects Cardiac Allograft Rejection with Molecular Specificity 
Qiang Tu 
Advisor: Chang Chang, PhD 
 
 
 
 
Optical techniques capable of in vivo and molecularly specific detection of disease 
markers are continuously being sought after with the goal of replacing invasive biopsy 
procedures that incur tissue incision and morbidity. Raman spectroscopy, with its 
chemical and molecular specificity as well as its intrinsic detection capability without the 
need for exogenous labeling and fixation, presents an attractive opportunity for minimally 
invasive in vivo diagnostics. However, medical applications of Raman spectroscopy have 
been largely limited by the complexity of tissue constituents. As a result, complicated 
post-experiment data processing is required and the attainable information is limited to a 
set of given a priori sample constituents, such as collagen, cholesterol and phospholipids. 
This work overcame such limitation by directly detecting a specific biomarker of cardiac 
allograft rejection and showed that spatially resolved Raman spectroscopy is capable of 
making molecular specific detection at the tissue level without exogenous labeling. This 
molecular specificity is achieved by detecting the strong and characteristic Raman 
spectral signature of serotonin, whose selective existence in rejected heart transplants 
serves as the molecular marker. By combining both medical and physical sciences, this 
work demonstrates the potential use of Raman spectroscopy in replacing the 
endomyocardial biopsy as the standard for post-transplantation rejection surveillance and 
presents a new paradigm in advancing clinical care. 
 xi 
The particular indole implicated in this study, serotonin, corroborates the increasingly 
recognized role of serotonin receptors in various immune responses including cardiac 
allograft rejection. Serotonin is both a ubiquitous neurotransmitter in the central nervous 
system and an important immunomodulator involved in various immune responses. The 
ability to unambiguously detect serotonin is therefore imperative in biomedical research. 
However, detection of serotonin and related indoles using immunohistochemistry has 
been largely limited by their small molecule size and the resultant uncertainty in antibody 
specificity. Here Surface-enhanced Raman spectroscopy (SERS) is showed to be capable 
of detecting and distinguishing serotonin from its various closely related precursors and 
metabolites. Comparing with traditional antibody-based methods, SERS is highly specific 
and capable of real-time detection. We expect this optical detection method to directly 
benefit a variety of immune and nervous systems studies involving serotonin. 
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CHAPTER 1. INTRODUCTION 
Heart transplantation is the therapy of last resort for patients with end-stage heart 
failure and its efficacy relies on the successful management of the recipient immune 
response
1
. Endomyocardial biopsy is the current standard of care for post-transplantation 
rejection surveillance of cardiac allografts
2
. Tissue samples are retrieved from the 
endocardium of the right ventricle and the severity of allograft rejection is graded 
histopathologically
3,4
. Like other biopsy procedures, endomyocardial biopsy is invasive, 
subject to sampling errors, and causes morbidity and rarely mortality. Its finite 
turnaround time also incurs unwanted patient anxiety. A less invasive and potentially 
real-time in vivo diagnostic method is therefore desired. 
 
Minimally invasive optical techniques capable of differentiating between diseased 
and normal tissues are attractive alternatives to invasive biopsy procedures. By probing 
the intrinsic molecular vibrations, Raman spectroscopy is capable of chemical and 
molecular specific detections without the need for exogenous labeling. In addition, no 
tissue removal or sectioning is required. The wavelengths of a typical probing laser and 
the Raman scattered light are both in the non-ionizing infrared region, further facilitating 
its use for in vivo biomedical applications. Minimally invasive optical fiber-based 
insertion devices such as catheters and endoscopes are also readily available
5,6
. More 
recently, Raman spectroscopy has been used to classify regions of diseased and normal 
tissues, and the underlying compositional differences can be determined given a priori 
knowledge of the tissues’ constituents, such as fat, collagen, cell nucleus, cell cytoplasm, 
and -carotene7,8. However, wider adoption of Raman spectroscopy in clinical settings 
 2 
has yet to be seen primarily due to the complicated post-experiment data processing and 
the resultant difficulty in obtaining molecular specificity. Here we utilize the strong and 
characteristic Raman spectral features of an aromatic amino acid derivative, serotonin, to 
directly identify rejected cardiac allografts. The potential use of Raman spectroscopy in 
detecting ring-structured endogenous molecular markers for clinical applications is 
demonstrated. 
 
This work is the first approach to use Raman spectroscopy to detect heart transplant 
rejection. An optical biomarker was discovered and used for the effective detection by 
Raman spectroscopy. It is the first SERS analysis on serotonin and its related molecules 
including melatonin and 5-HIAA to my best knowledge. This work successfully qualifies 
the relative concentrations of indole molecules in mixed solution. 
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CHAPTER 2. BACKGROUND 
2.1 Raman Spectroscopy 
Raman spectroscopy is a powerful technique which detects molecules vibrations by 
Raman scattering. It is widely used to obtain molecular structure information, 
qualitatively identify the substances, and quantitatively or semi-quantitatively determine 
the amounts of substances in a sample, which can be solid, liquid, or vapor. Raman 
spectroscopy typically uses a non-ionizing laser as the excitation source. The incident 
photons can be absorbed, scattered, and/or pass through the material without interaction. 
If the energy of the incident photon matches the energy gap between the ground state and 
an excited state of a molecule, the photon will most likely be absorbed and the molecule 
is promoted to the excited state. Fluorescence occurs when the excited molecule 
subsequently relaxes to the ground state by emission. Scattering takes place on the other 
hand as the incident photon distorts the electron clouds. Two types of scattering typically 
exist in the visible-light and near infrared (NIR) spectral range, Rayleigh and Raman 
scattering. The more intense form, Rayleigh scattering, happens when only the electron 
clouds are distorted. This is considered an elastic process as no appreciable energy 
exchange occurs. However, if the vibrational state of the molecule is altered, energy 
transfer occurs, either from the photon to the molecule or vice versa. The process 
becomes inelastic and is named Raman scattering. This is in general a weak process 
involving approximately one in every 10
6
~10
8
 scattered photons.
9-11
  
 
Depending on the direction of energy transfer between the molecule and the photon, 
Raman scattering can be further categorized into two subtypes: Stokes and anti-Stokes. 
Stokes scattering takes place when the molecule absorbs energy from the incident photon 
 4 
and elevates itself from a lower energy state to an excited vibrational state. On the other 
hand, due to thermal perturbation or prior external excitation, the molecule may already 
be in an excited vibrational state before interacting with the incident photon. In this case 
anti-Stokes scattering may result such that the molecule releases energy upon interacting 
with the incident photon and subsequently returns to a lower energy state. The scattered 
photons in an anti-Stokes process therefore are of higher energy than the incident photons. 
Since at room temperature most molecules are in the ground state, Stokes scattering 
typically dominates. Stokes scattering is therefore commonly recorded for Raman 
spectroscopy unless special experimental conditions are arranged. Raman band shifts, i.e. 
the energy difference between the incident and scattered photons, are typically described 
in wavenumber. The most commonly used unit to denote wavenumber is cm
-1
, and it is 
equivalent to joule by a conversion factor (hc), where h is the Planck constant and c is the 
speed of light. Figure 1 illustrates the Rayleigh, Stokes and anti-Stokes scattering 
processes. 
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Figure 1. Energy diagram for Rayleigh and Raman scattering processes. Rayleigh 
scattering is the most intense scattering process, and Stokes scattering predominates 
over anti-Stokes scattering at room temperature. Thickness of the arrows indicates 
the relative intensity of the three processes (not to scale). Adapted from reference 
12
. 
 
 
A typical laboratory Raman spectroscopy system is shown in Figure 2. The incident 
laser irradiates the sample via an optical microscope, and the Raman scattered photons 
are collected into a spectrometer following appropriate filtering. Lasers at various visible-
light and NIR wavelengths can be used as the excitation source. For example, a HeNe 
laser has a wavelength of 633 nm, and a Ti: sapphire laser is tunable from 650 nm to 
1100 nm. When examining biological samples, longer wavelength excitations typically 
produce less fluorescence background and are therefore preferred. 
 
 6 
 
Figure 2. A typical laboratory Raman spectroscopy system. Adapted from reference 
12
. 
 
 
 
 
 
 
 
 
 7 
2.2 Surface Enhanced Raman Spectroscopy 
Surface-enhanced Raman spectroscopy (SERS) increases the Raman signal level by 
exploiting the interaction between the molecule and a nano-scale metal surface. Raman 
signals thus emitted are strongly enhanced by a factor of 10
3
 – 1014, depending on the 
definition of the enhancement factor.
13,14
 For substrate-based SERS experiments, the 
most widely used definition for average SERS enhancement factor is SERS Surf
RS Vol
I N
EF
I N
 , 
where SERSI  and RSI  are the SERS and regular Raman intensity, respectively.  VolN  is the 
average number of molecules in the scattering volume for regular Raman, and SurfN  is 
the average number of adsorbed molecules in the scattering volume for SERS. For SERS 
in colloidal solutions, the analytical enhancement factor or apparent enhancement factors 
(AEF) are calculated by SERS SERS
RS RS
I C
AEF
I C
 , where SERSI  and RSI  are SERS and regular 
Raman intensities of normalized Raman spectra at the selected band, respectively. SERSC  
and RSC  are concentrations of the target molecule in colloidal and aqueous solutions, 
respectively. SERS is capable of detecting molecules in extremely low concentrations, 
making it an attractive technique for biomedical applications.  
 
Although the exact theoretical foundation of SERS is still illusive, it is generally 
agreed that SERS consists of two major underlying physical mechanisms: the 
electromagnetic field effect and the chemical charge transfer effect.
15,16
 The 
electromagnetic effect is a result of the excitation of surface plasmon by the incident laser, 
while the charge transfer effect is caused by the electron exchange between the molecule 
 8 
and the metal colloid.
17
 Surface plasmon is the resonant oscillation of conduction 
electrons on a metal surface induced by an electromagnetic field. It is well known that the 
exposure of surface plasmon to laser irradiation increases the lattice temperature,
18,19
 and 
this surface plasmon induced heat generation has been identified as the potential cause of 
SERS signal reduction seen in prolonged irradiation of nanoparticles.
20
 Note that since 
SERS results from the interaction between the molecule under test and the nano-scale 
metal surface, the band shifts, relative peak intensity, and peak bandwidths in the SERS 
spectra are different from those in the Raman spectra of the same molecule. 
 
2.3 Analysis Methods in Raman Spectroscopy 
Raman spectra obtained from biological samples often contain significant amounts of 
fluorescence background. Since Raman spectral differences between normal and diseased 
tissues are generally subtle, effective data processing algorithms are often required for 
data analysis and interpretation. 
 
2.3.1  Fluorescence background removal 
As mentioned above, Raman spectra collected from tissues are composed mainly of 
Raman scattering and intrinsic tissue fluorescence. To eliminate the fluorescence 
background, a polynomial function that fits to the fluorescence profile is usually 
subtracted from the Raman spectra.
21-24
 While there is no consensus on the optimal order 
of the polynomial function, fourth- and fifth-order polynomials are most commonly 
employed.
24-28
 
 
 9 
2.3.2 Multivariate data analysis 
Raman spectra contain various overlapping Raman bands. As a result, it is difficult to 
visually inspect and interpret the spectral data. Multivariate spectral analysis methods are 
often used to process the Raman spectra and facilitate data interpretation. Spectral 
analysis methods are generally categorized as either supervised or unsupervised. For 
unsupervised analyses, such as cluster analysis (CA) and principle component analysis 
(PCA), no a priori knowledge of class characteristics is required but to be determined 
from the analysis itself. In contrast, in a supervised analysis, the number of classes and 
representative samples of each class are known a priori, as is the case in linear 
discriminant analysis (LDA), regression analysis and artificial neural networks (ANN).
29
 
Several commonly used analysis methods are introduced below.  
 
2.3.2.1 Hierarchical clustering 
Hierarchical clustering is a cluster analysis method in which Raman spectra are 
grouped according to their similarities defined by the distance matrices. A distance 
matrix measures dissimilarity among a group of objects, i.e. Raman spectra in this case. 
For example, the most commonly used distance metric is the Euclidean distance where a 
Raman spectrum with p  wavenumbers is expressed as 1 2[ , , ]px x xx , and the 
distance between two Raman spectra ix  and jx  is defined as 
1
2
2
1
( ) ( )
p
ij i j ik jk
k
d x x

 
    
 
x x . The clustering process is repeated at different levels 
to produce a tree structure, called the dendrogram, and the spectra from normal and 
 10 
diseased samples are discriminated at the end of the process. Hierarchical clustering is 
widely used in analytical Raman spectroscopy.
30,31
 
 
2.3.2.2 Principle component analysis 
Principle component analysis (PCA) is one of the most commonly used unsupervised 
classification method in Raman spectroscopy. Raman spectra contain intensity 
information obtained at a large number of different wavenumbers. Each of these 
wavenumbers can be regarded as an independent dimension, on which the Raman 
spectral data is measured. PCA reduces the dimensionality of the original Raman data set 
with most of its variance retained in the selected principle components.
21,26,32-36
 PCA has 
been successfully used in multivariate Raman spectral analysis and is widely accepted for 
data interpretation. A brief overview of PCA is provided below for a typical diagnostic 
Raman spectral data classification process. 
 
The set of Raman spectra obtained from a diagnostic experiment can be expressed as 
an m by n matrix X, 
 
11 12 13 1
21 22 23 2
31 32 33 3 1 2 3
1 2 3
n
n
n n
m m m mn
x x x x
x x x x
x x x x
x x x x
 
 
 
  
 
 
  
X x x x x ,  
 
where n is the number of Raman spectra taken in the experiment, m is the total number of 
spectral wavenumbers, and 
ix  is a column vector of length m representing the i
th
 Raman 
spectrum. The covariance matrix CX of the original Raman data set X can then be 
 11 
determined, as well as the eigenvectors of CX. The resulting eigenvector matrix W is 
given by 
 1 2 3 mW w w w w , 
where 
iw  is a column vector of length m representing the i
th
 eigenvector of CX. Note that 
the eigenvectors are arranged with descending eigenvalues, i.e. decreasing contributions 
to the overall variance of the Raman data set. 
 
The principle component scores P is obtained by projecting the original Raman data 
set X onto the new basis spanned by the eigenvectors, i.e.   
 T 1 2 3 m P W X p p p p , 
 
where pi is a column vector of length n representing the scores of the i
th
 principle 
component for each of the n measurements in the Raman data set. Since the principle 
components corresponding to the largest eigenvalues account for most of the variations in 
the data set, classification of Raman spectra in most cases can be achieved with these first 
few principle components. PCA is therefore a powerful analytic tool for dimensionality 
reduction in Raman spectroscopy.   
 
2.3.2.3 Linear discriminant analysis 
Linear discriminant analysis (LDA) is another commonly used spectral data 
classification method. Since the projection axes produced by PCA do not always provide 
clear boundaries for between-class discrimination, LDA is often used to improve the 
class separation following PCA. One of the most common LDA approaches is Fisher’s 
criterion. It is a supervised analysis that maximizes the between-class variance while 
 12 
minimizing the within-class variance in a set of Raman spectra. Effective class separation 
is achieved by projecting the Raman data into a new eigenvector set.
26,37-40
 This method 
applied to a two-class problem is briefly described below. 
 
Within-class and between-class scatter matrices are used to formulate the criterion. 
The within-class scatter matrix is defined as 
 T
1,2 i
W i i
i C 

x
S = (x -m )(x -m ) , 
where x is a column vector representing an individual Raman spectrum in class iC , and 
im  is the mean of the Raman spectra in class iC , i =1,2. The between-class scatter 
matrix is given by 
 T1 2 1 2( )( )B  S = m m m m , 
where 1m  and 2m  are defined above. The Fisher’s criterion function,  
T
T
( ) B
W
J 
w S w
w
w S w
 is 
used to evaluate the classification. A vector w  that maximizes the function ( )J w  is the 
solution to the generalized eigenvalue problem B WS w S w . The eigenvector w  is then 
used as the new basis vector. Once the data set is transformed onto this vector, Euclidean 
distance can be used for data classification. However, some data located in the middle of 
the two classes might not be easily categorized. 
 
2.3.2.4 Artificial neural network 
While LDA can only discriminate classes that are linearly separable, artificial neural 
network (ANN) is a nonlinear method capable of multi-dimensional bounding problems. 
 13 
ANN emulates the process of human mind by employing artificial neuron functions in 
which each neuron provides an output value based on multiple inputs. Typically, an ANN 
consists of multiple layers, including the input layer, the hidden layer and the output layer. 
Neurons on the input layer take the Raman spectral data as inputs and the classifications 
are made at the output layer. Each neuron in the hidden layers sums up the inputs from 
neurons in preceding layers with certain weights. These “middle” neurons then send out 
their outputs after some nonlinear operations, such as hyperbolic tangents, step functions, 
and sigmoid functions. The weights are computed using a set of known data during the 
training process. The number of hidden layers, the neuron functions, and the form of the 
data are crucial parameters for an effective ANN design.
41
 Note that which Raman 
spectral features to be used as inputs should be carefully chosen for optimal classification. 
One example of Raman spectral analysis using ANN is the single-cell diagnosis of 
colorectal cancer.
42
 
 
2.3.2.5 Ordinary least squares regression 
Ordinary least squares (OLS) is a commonly used linear regression method that 
minimizes the sum of squared distances between experimental data and the 
corresponding fitted curve. OLS is often used to determine the compositional 
concentrations of a tissue sample, where the sample spectrum is fitted to the individual 
composition’s Raman spectra and a weighted sum is obtained from the fitting 
coefficients.
31,43
 Briefly, the Raman spectrum of a tissue sample (or solution mixture) can 
be expressed as an m × 1 column vector  
T
1 2 3 my y y yy , where m is the 
number of wave numbers at which Raman shifts are recorded. Similarly, Raman spectra 
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of its component chemicals can be expressed as column vectors and put together as an m 
× n matrix Z, 
11 12 13 1
21 22 23 2
31 32 44 3
1 2 3
n
n
n
m m m mn
z z z z
z z z z
z z z z
z z z z
 
 
 
 
 
 
  
Z , 
where n is the number of component chemicals, and m is the same set of wavenumbers as 
defined above. The OLS coefficient  
T
1 2 3 n   β  needs to satisfy 
 y Zβ u , where u is an m × 1 error vector. OLS minimizes the residual sum 
of squares 
2 T( ) ( )SSR  y - Zβ y - Zβ y - Zβ  by setting the derivative of SSR with 
respect to β equal to 0. The OLS estimator βˆ is then calculated to be T 1 Tˆ ( )β Z Z Z y .44 
Considering that the weights of components are positive, a nonnegativity constraint is 
applied in this case to avoid negative fitting coefficients and this variant of OLS is called 
nonnegative least squares (NNLS). 
 
 
 
 
 
 
 
 
 
 15 
CHAPTER 3. CURRENT RELATED RESEARCH 
3.1 Current Research Using Raman Spectroscopy 
3.1.1 Cancer detection 
Cancer is the second most common cause of death in the United States.
45
 Efficacious 
cancer treatments rely on early detection and accurate diagnosis. Various Raman 
spectroscopic studies on cancers have been reported,
31,36,46-49
 and here we review its use 
on three most commonly seen carcinomas, i.e. breast, colorectal and cervical cancers. 
 
3.1.1.1 Breast Cancer 
Breast cancer has the highest rate of occurrence in the United States among the 
female population in 2010.
45
 Numerous studies have investigated the application of 
Raman spectroscopy on the detection of normal, precancerous and cancerous breast 
tissues.
22,34,43,50,51
 For instance, Haka and colleagues have demonstrated the ability of 
Raman spectroscopy to distinguish between normal, benign, and malignant lesions of 
breast ex vivo, with a sensitivity of 94% and a specificity of 96%.
43
 Tissues in four 
pathological conditions were examined and classified, including normal, ﬁbrocystic 
change, ﬁbroadenoma, and inﬁltrating carcinoma. Raman spectra of breast tissues were 
fitted to those of individual breast tissue components including fat, collagen, cell nucleus, 
epithelial cell cytoplasm, calcium oxalate, calcium hydroxyapatite, cholesterol-like lipid 
deposits, and -carotene. This approach is based on the assumption that the Raman 
spectrum of a mixture is a linear combination of the spectra of its components. Variations 
in the fitting coefficients reflected the chemical and morphologic changes of the breast 
tissue due to carcinogenesis. Fitting coefficients of fat and collagen have been identified 
as the key parameters used for diagnostic differentiation. Normal breast tissues are 
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composed of fat predominately, and all abnormal breast tissues show increased 
percentage of collagen, due to the formation of fibrosis. Fibroadenoma can then be 
further separated from infiltrating carcinoma by its lower fat content, since fibroadenoma 
grows by pushing the fat aside while infiltrating carcinoma infiltrates between fat cells 
and retained the fat in situ. These results were consistent with known breast pathology 
and therefore validate the use of Raman spectroscopy for breast cancer detection ex vivo. 
The clinical potential of Raman spectroscopy was also demonstrated by the same authors 
with the use of an optical fiber probe for in vivo Raman studies.
50
 The spectral data were 
analyzed in real time and the diagnosis results were displayed intraoperatively.  
 
Rehman and co-workers quantitatively examined the Raman spectral differences 
between different grades of invasive ductal carcinoma (IDC) and ductal carcinoma in situ 
(DCIS).
52
 For both IDC and DCIS, the spectral intensity of selected Raman peaks 
increased with advancing grades, indicating Raman spectroscopy’s potential for 
quantitative carcinoma grading. 
 
Instead of examining breast tissues directly, Pichardo-Molina’s group studied serum 
samples from breast cancer patients and demonstrated the use of Raman spectroscopy for 
minimally invasive diagnostics.
40
 Seven Raman band ratios were used for classification 
and spectral differences were observed between serum samples of breast cancer patients 
and normal healthy subjects. Using principle component analysis (PCA) and linear 
discriminant analysis (LDA), the sensitivity and specificity were reported to be 97% and 
 17 
78%, respectively. However, the underlying molecular mechanism of these differences 
was not reported.  
 
Raman spectroscopic imaging technique has gained popularity recently in cancer 
research.
30,53-56
 Comparing with other standard imaging methods such as 
immunofluorescence and immunohistochemisty, Raman spectroscopic imaging is capable 
of visualizing the samples without extrinsic labeling, thus minimizing sample 
perturbation. In addition, the much needed chemical and structural information of the 
sample are provided by Raman spectral analysis.
57,58
 Mariani and co-workers have 
applied Raman imaging to the detection of nuclear membrane lipid fluctuations in 
senescent epithelial breast cancer cells.
59
 In this study, Raman images were composed 
based on the Raman peak intensity of CH- stretching [Figure 3(B)]. Subcellular localities 
such as the nucleus were accurately imaged, and differences in lipid and glycoprotein 
components were detected. 
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Figure 3. Visual (A) and Raman imaging (B, C) of single control and senescent 
MCF-7/NeuT cells. Raman images (B) were composed specifically from CH- 
stretching, and were analyzed using unsupervised hierarchical cluster analysis (C). 
Adapted from reference 
59
. 
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3.1.1.2 Cervical Cancer 
Cervical cancer is the second most common malignancy in women worldwide, with 
more than half a million cases diagnosed and approximately 288,000 related death each 
year.
60
 Currently Papanicolaou smear is the most commonly used screening method for 
cervical cancer with a detection specificity of 96.8%, but a sensitivity of only 55.4%.
61
 
Raman research in this area has focused on achieving comparable or better specificity 
and sensitivity numbers than the Papanicolaou smear.  
 
Algorithms were designed to discriminate between normal and diseased cervical 
tissues. Using a logistic regression algorithm Robichaux-Viehoever, et al. were able to 
distinguish high-grade dysplasia from benign tissues with a sensitivity of 89% and a 
specificity of 81%.
62
 The spectra were collected in vivo using a fiber-optic probe.
5
 
Employing non-linear algorithms, Kanter and colleagues achieved a sensitivity of 98% 
and a specificity of 96%.
63
 They have also reported that by incorporating into their 
algorithm the patient’s hormonal status, particularly the menstrual cycle and the 
menopausal state, the classification accuracy can be further improved.
64
  
 
New experimental techniques have also been used to improve detection accuracy in 
cervical cancer. While most Raman studies are performed in the “fingerprint” spectral 
region with wavenumbers below 1500 cm
-1
,
9
 Mo and colleagues have investigated the 
high wavenumber region (2800 ~ 3700 cm
-1
) for cervical cancer diagnosis, and achieved 
a diagnostic specificity and sensitivity of 97.8% and 93.5%, respectively.
38
 Kamemoto’s 
group compared the use of both fingerprint (775 ~ 975 cm
-1
) and high wavenumber 
regions (2800 ~ 3100 cm
-1
) for in vitro cervical cancer detection, and found that Raman 
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bands at the low wavenumber region [Figure 4(B)] provide more information on specific 
molecular and chemical changes in the tissue, while Raman spectra at the high 
wavenumber region [Figure 4(C)] have higher detection sensitivity due to stronger 
Raman signals and significantly less fluorescence background from the optical fibers.
38,60
  
Molecular etiology of the observed Raman spectral differences between normal and 
diseased cervical tissues was also studied.
32,60
 Comparison between normal and 
malignant cervical tissues showed that Raman spectra from normal cervical tissues 
feature characteristics of structural proteins such as collagen. For malignant cervical 
tissues, sharper amide I, minor red shift in CH2 and sharper amide III indicated the 
presence of DNA, lipids and non-collagen proteins. 
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Figure 4.The as-recorded Raman spectra of normal cervical squamous cells and 
invasive cervical cancer cells are shown in (A). Details of these Raman spectra in the 
ﬁngerprint region of 700 to 1800 cm-1 and the high wavenumber region of 2800 to 
3100 cm
-1
 are enlarged in (B) and (C), respectively, for display. Adapted from 
reference 
60
. 
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3.1.1.3 Colorectal Cancer 
Colorectal cancer is the third most common malignancy in the United States.
45
 An 
estimated 142,570 new cases and 51,370 related deaths are expected for 2010. Current 
standard of practice utilizes a white-light endoscope to screen and excise biopsies on 
suspected sites. Difficulty exists in that early neoplasia and subtle lesions might evade the 
endoscopic survey, and biopsies are impractical for patients with multiple suspicious 
lesions.
65
 Optical biopsy using Raman spectroscopy is therefore an attractive alternative. 
Several groups have thus investigated and developed effective detection/classification 
algorithms. Widjaja and colleagues, for instance, combined PCA and support vector 
machines (SVM) to classify different types of pathologic colonic tissues, including 
normal, polyps and cancers. Sensitivity and specificity greater than 98% have been 
reported.
65
 Beljebbar, et al. investigated the spatial distribution of molecular changes on 
the adenocarcinoma ex vivo.
30
 Pseudo-color maps of normal and cancerous colonic 
tissues were generated using Raman spectra of individual tissue constituents, including 
proteins, lipids, collagen, nucleic acid and mucus. These Raman maps were shown to 
correlate with hematoxylin and eosin (H&E) stains, demonstrating the use of proteins and 
nucleic acids as potential spectroscopic biomarkers for the differentiation of 
adenocarcinomatous tissues.  
 
Laser Tweezers Raman spectroscopy (LTRS) has also been investigated for single-
cell colorectal cancer diagnosis.
66
 At the early stages of colon cancer development, the 
epithelium layer on the luminal surface carries diagnostic information while the 
underlying bulk tissues are mostly irrelevant. In order to minimize the fluorescence 
background from the bulk tissues, laser tweezers are used to trap single cells from the 
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epithelium and inspect them in isolation using Raman spectroscopy. Sensitivity of 86.3% 
and specificity of 86.3% have been reported with LTRS.
42
 
 
3.1.2 Allograft rejection 
Allograft transplantation is the last resort therapy for patients with failed organs. Its 
efficacy relies on the successful management of the recipient’s immune responses. 
Several studies using Raman spectroscopy to detect acute allograft rejection after 
transplantation have shown promising results.
67-69
 Raman spectroscopy has been used to 
detect acute rejection after renal transplantation. Acute rejection typically occurs in 15% - 
20% of the patients within the first year of renal transplant, and currently the most 
commonly used diagnostic indicator is serum creatinine elevation (SCE). However, this 
method has been shown to have low sensitivity and specificity, since serum creatinine 
level can be affected by other disease conditions. In addition, serum creatinine level 
elevates only after significant histological damages have already taken place.
68
. Using 
Raman spectroscopy, Brown, et al. observed significant spectral differences between 
activated and naive T lymphocytes, and reported a sensitivity and specificity of 95.7% 
and 100%, respectively.
69
 This result demonstrates the potential of Raman spectroscopy 
as a minimally invasive screening tool for acute renal transplantation rejection. 
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3.2 Current research using SERS 
3.2.1 SERS for biomarkers 
SERS has been used to detect various biomolecules and proteins, such as glucose, 
hemoglobins, RNAs and pathogens.
70-73
 Detection using SERS is especially 
advantageous for small signaling molecules that often lack recognizable epitopes for 
antibody-based immunohistochemistry. For instance, Huang and co-workers conjugated 
gold nanorods to anti-epidermal growth factor receptor (anti-EGFR) antibodies and 
demonstrated its use as a potential cancer diagnostic tool.
74
 Due to its large curvatures, 
gold nanorod in theory has the strongest surface electromagnetic field compared with 
other colloid shapes.
75
 In this study, gold nanorods were coated with poly(styrene 
sulfonate) to stabilize the colloids and to reverse the surface charge polarity from 
negative to positive for antibody conjugation. Minimal Raman signals were observed on 
normal cells, while significantly stronger Raman signals were detected on cancer cells, 
demonstrating specific antibody binding. The detection specificity was provided by the 
antibody and the SERS signal served simply as the readout. Other novel SERS based 
techniques such as the nanoprobe technology were also developed.
76-78
 As an example, 
the molecular sentinel (MS) nanoprobe consisted of a DNA hairpin probe with one end 
binding to a silver nanoparticle, and the other tagged with a SERS signal reporter. In the 
absence of the target DNA, significant SERS signals were observed since the SERS 
signal reporter was close enough to the silver nanoparticle on the other end of the folded 
stem-loop structure [Figure 5 (left)]. While in the presence of the complementary target 
DNA, the SERS signal was significantly reduced due to the semi-loop unfolding and 
separation of the SERS signal reporter from the silver nanoparticle [Figure 5 (right)]. 
Multiplexing was achieved by mixing two MS nanoprobes specific to the breast cancer 
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biomarker genes, erbB-2 and ki-67, to simultaneously detect both target DNAs present in 
the sample. 
 
 
 
Figure 5. SERS-based molecular sentinel (MS) nanoprobes. The MS nanoprobe 
shown on the left of the figure is in the closed state and generates a strong SERS 
signal due to the proximity between the Raman label and the silver nanoparticle. In 
the presence of the complementary target DNA, the MS nanoprobe switches to the 
open state as shown on the right of the figure, and the SERS signal is significantly 
reduced due to the separation of the Raman label from the silver nanoparticle. 
Adapted from reference 
76
. 
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3.2.2 SERS for in vivo detection 
The application of SERS for in vivo diagnostics in complex living systems is a 
challenging task. Surface of the nanoparticle must be biocompatible and placed in vivo 
without causing damage to the living system. In addition, the in vivo environments are 
awash with a variety of molecules and contaminants that may deactivate the SERS 
surface or interfere with the interested Raman signals. Moreover, the concentrations of all 
molecules, both targets and contaminants, are constantly changing. Recently several 
successful in vivo SERS experiments have been demonstrated.
79-83
 Stuart and colleagues 
performed in vivo SERS on rats and quantitatively determined glucose concentration in 
the interstitial fluid.
84
 The SERS-based sensor was fabricated using silver films over 
nanosphere (AgFON) [Figure 6(B)]. Hydrophilic pockets were formed around the sensor 
and partitioned glucose to the SERS-active surface, while excluding other molecules in 
the interstitial fluid such as plasma proteins. A glass window was surgically placed on the 
rat, allowing the sensor to be in contact with interstitial fluid and optically accessible for 
Raman spectroscopy [Figure 6(A)]. In their more recent work,
85
 the window was 
removed and SERS spectra were collected transcutaneously. In order to obtain Raman 
signals deeper in the tissues, spatially offset Raman spectroscopy (SORS) was applied, in 
which the Raman scattered light was collected with a spatial offset from the point of laser 
incidence.
86,87
 In another recent study, Qian and co-workers demonstrated in vivo tumor 
detection using SERS with PEGylated gold nanoparticles.
88
 The SERS sensor was 
prepared by binding the reporter molecule diethylthiatri-carbocyanine (DTTC) to the gold 
colloids. A mixture of thiol-PEG and a heterofunctional PEG (SH–PEG–COOH) was 
then coated to stabilize the gold colloid-DTTC complex. Cancer cell-specific single-chain 
variable fragment (ScFv) B10 antibodies were conjugated at the last step. As shown in 
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Figure 7(C), the sensor was injected through tail vein into the mice bearing human head 
and neck tumors. Highly resolved SERS signals were observed specifically at the tumor 
site [Figure 7(A, B)]. Keren’s group demonstrated in vivo Raman imaging in a similar 
study using single-walled carbon nanotubes (SWNT).
89
 Since SWNTs inherently exhibit 
a strong Raman peak at 1593 cm
-1
, Raman imaging using SWNTs does not rely on SERS 
reporter molecules and therefore requires fewer conjugation processes. 
 
 
 
Figure 6. In vivo glucose detection using SERS. A rat with a surgically implanted 
sensor and optical window was examined by a conventional laboratory Raman 
spectroscopy system (A). The SERS-based sensor was fabricated using silver films 
over nanosphere (AgFON) (B). The resultant nano-structure (C) is shown using an 
atomic force microscope. After functionalization, a reflectance spectrum (D) was 
collected to determine the position of the localized surface plasmon resonance 
(LSPR). Adapted from reference 
84
. 
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Figure 7. In vivo SERS detection of tumor biomarker EGFR using ScFv-antibody 
conjugated gold nanoparticles. The bottom panels show the experimental setup. The 
top panels show spectra obtained from the tumor (red) and the liver (blue) by using 
targeted (A) and non-targeted (B) nanoparticles. In vivo SERS spectra were clearly 
observed from the tumor site using targeted nanoparticles, but not with non-
targeted nanoparticles. Adapted from reference 
88
. 
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3.3 Emerging techniques of Raman spectroscopy 
3.3.1 Single-walled carbon nanotube 
Single-walled carbon nanotube (SWNTs) is an useful diagnostic tool in 
nanomedicine.
90-94
 It has been shown that conjugation to SWNT improves the 
permeability, as well as enhances the retention, of various functional moieties in the 
tumor tissues.
95,96
 This enhanced permeability and retention (EPR) effect of SWNT has 
been explored for drug delivery where various biomolecules such as chemotherapeutic 
agents, proteins and DNA were conjugated to SWNT and delivered to tumor sites.
97-100
 
SWNT’s intrinsic Raman peak at 1593 cm-1 (G-band) is typically used as the 
unambiguous marker to detect SWNT conjugates in drug delivery and Raman imaging 
studies.
101-104
 In an in vivo cancer drug delivery study, paclitaxel (PTX), a chemotherapy 
drug was conjugated to  SWNTs and injected into mice.
99
 Raman spectroscopy was used 
to quantify the pharmacokinetics and biodistribution of this SWNT-PTX conjugate 
without any radio or fluorescent label. Raman imaging is another area where SWNT finds 
important applications.
89,102
 Zavaleta and co-workers have shown noninvasive Raman 
imaging of tumors on mice in vivo using SWNTs.
102
 The SWNTs were linked to 
arginine-glycine-asparatic acid (RGD) peptides, which specifically target integrin v3, 
an integrin overexpressed in angiogenic vessels and various tumor cells. After 
subcutaneous injection of this SWNT-RGD conjugate, in vivo Raman images of tumor 
were obtained using SWNT’s G-band intensity. In a more recent study, Liu et al. 
successfully performed multicolor Raman imaging of living cells by multiplexing 
different isotope compositions.
105
 SWNTs made of carbon-12 (
12
C), carbon-13 (
13
C), and 
12
C/
13
C mix were used and each presented different G-band peak positions at 1590, 1528, 
and 1544 cm
-1
, respectively. These three types of SWNTs were conjugated to Herceptin 
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(anti-Her2), Erbitux (anti-Her1), and arginine-glycine-aspartic acid (RGD) peptides, 
recognizing Her2/neu, Her1/EGFR, and integrin v3 cell-surface receptors, respectively. 
These SWNT conjugates are then administered in vitro and after incubation, multiplexed 
three-color Raman images were obtained, clearly identifying the existence of the three 
targeted cell receptors. Note that G-band spectral positions are key to distinguishing the 
three multiplexed colors in Raman imaging and it was recently shown that up to five 
different colors could be achieved by varying the 
12
C/
13
C ratios in SWNTs.
106
 
 
3.3.2 Multiplexed SERS imaging 
Multiplexed Raman imaging is capable of detecting multiple targets simultaneously 
and it has attracted great interests recently.
107-110
 Gold nanoparticles are typically used as 
the tag in multiplexed SERS imaging for their narrow and strong SERS bands. In 
addition, silica coated gold nanoparticles are biocompatible and nontoxic. In a recent 
work, Zavaleta et al. achieved five color multiplexed Raman imaging in vivo using five 
SERS nanotags adsorbed on gold nanoparticles.
111
 Each nanotag generated a unique 
Raman signal, which is used as a multiplexed channel and assigned an arbitrary color in 
the resultant image. These five types of nanotagged gold nanoparticles were 
simultaneously injected through the tail vein and accumulated in the liver where a 
multiplexed five color Raman image was obtained.  
 
Using functionalized silver nanoparticles, Kennedy and co-workers demonstrated 
multiplexed SERS imaging of cell surface proteins in vitro.
112
 SERS signals from four 
differently functionalized nanoparticles were separated using least square fitting and the 
spatial co-localization between the targeted proteins were visualized in the multiplexed 
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SERS image. Other in vitro multiplexed SERS imaging works include cancer cell line 
identification where specific nanotags were used to recognize their respective biomarkers 
found on cancer cells.
113
 
 
3.3.3 Photothermal effect 
Photothermal effect is an important feature of metal nanoparticles. The exposure of 
metal nanoparticles to laser induces an increase in temperature.
18
 Application  of this 
laser-induced thermal effect in Raman spectroscopy has recently been demonstrated 
where plasmon heating was used to produce SERS-active micro spots on colloidal 
crystals.
114
 Polystyrene (PS) colloidal nanospheres were first coated with a 10nm layer of 
gold nanoparticles and then with a 50 nm layer of amorphous TiO2 deposited by atomic 
layer deposition (ALD). The resulting PS/Au/TiO2 core/shell nanospheres are assembled 
as colloidal crystals. When irradiated by a laser beam, the gold interlayer was strongly 
absorbing and the heat generated decomposed the polymeric spheres. A bowl-like pit was 
formed as a result, and the SERS effect of Methylene Blue adsorbed on these spots was 
demonstrated.  
 
3.3.4 Core-Shell nanoparticle structure for improved SERS reproducibility 
Strong signal enhancement, high reproducibility and stability are critical for effective 
SERS phenomenon.
115
 SERS studies using metal nanoparticles typically suffer from the 
desorption of Raman labels or target molecules from the metal surface, and the 
interference from the environment such as non-target molecules and other surrounding 
metal nanoparticles. A core-shell structure offers an effective solution to those stochastic 
interventions, in that the shell capsulates the Raman labels or target molecules around the 
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metal core and prevents the adsorption of other molecules as well as the aggregation of 
nanoparticles themselves. Various shell materials have been investigated, including 
polymers, silica and metal.
88,116-119
 Among them, the stability and biocompatibility of 
silica makes it an attractive choice in medical research. Li and co-workers have 
developed ultra-thin silica-coated gold nanoparticles with strong SERS signal and 
minimal gold aggregations.
116
 Using etching technology, Roca’s group developed silica-
void-gold nanoparticles to prevent aggregations while allowing molecules to diffuse 
through the porous silica membranes and interact with the entrapped gold core.
120
 In a 
more recent study Lim et al. have demonstrated gold core–shell nanoparticles with highly 
uniform and reproducible SERS signals.
121
 The Raman labels trapped within the gap 
generated strong and highly quantitative SERS signals with 633 nm laser excitation. The 
development of new nanoparticles continues to expand the application of Raman 
spectroscopy in biology and medicine. 
 
Table 1 summarizes the applications of Raman spectroscopy reviewed above, 
including the types of analysis, experimental apparatus, and analysis methods. 
 
3
3
 
 
Table 1. Diagnostic applications of Raman spectroscopy. Adapted from reference 
12
. 
 
Raman application 
Experimental setup 
Analysis method Reference 
Wavelength 
(nm) 
Power 
(mW) 
Exposure 
time (s) Other 
Cancer 
detection 
Breast 
cancer 
830 100~150  10~30   Nonnagative least square (NNLS) 
43
 
830 82~125      1 Probe NNLS 
50
 
786 N/A  4   Raman shifts 
52
 
830 65  10   PCA-LDA 
40
 
514.5 8  N/A   Hierarchical cluster 
59
 
Cervical 
cancer 
785 80  5~15 Probe Logistic regression 
62
 
785  80  5 Probe Maximum representation and discrimination feature (MRDF) 63
 
Sparse multinomial logistic regression (SMLR)  
785  15  60 Probe PCA-LDA 
38
 
785  10  60   Raman shifts 
60
 
785  100  30   PCA 
32
 
Colorectal 
cancer 
785  300  5 Probe PCA-Support vector machines (SVM) 
65
 
785  70   N/A  
  
  
  
PCA 
30
 Hierarchical cluster 
Multiple least squares (MLS) 
782.5  11.5  60 LTRS PCA-Logistic regression 
66
 
782.5  11.5  60 LTRS PCA-Artiﬁcial neural network (ANN) 
42
 
Allograft 
rejection 
Cardiac 
rejection 
785  100  10  PCA 
67
 
Renal 
rejection 
785/514.5  8~12  10  PCA-Discriminant function analysis (DFA) 
69
 
SERS for 
Biomarker 
  785  100  20  NNLS 
25
 
  785  25  10  Raman shifts 
74
 
  633  N/A N/A  Raman shifts 
76
 
SERS for in   785  50  120  Partial least squares  
84
 
 
3
4
 
vivo   785  20  2  Raman shifts 
88
 
SWNT 
 N/A 100 2  Raman imaging using G-band 
99
 
 785 100 3/10  Raman imaging using G-band 
102
 
 785 80 0.5  Raman imaging using G-band 
105
 
SERS 
imaging 
 785 60 N/A  Raman imaging using SERS peaks 
111
 
 633 N/A N/A  Raman imaging using SERS peaks 
112
 
Core-shell 
nanoparticle 
 633 0.5/4 30/60  Raman shifts 
116
 
 633 2 50  Raman shifts 
120
 
 633 0.3 10  Raman shifts 
121
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CHAPTER 4. DETECTION OF CARDIAC TRANSPLANT REJECTION USING 
RAMAN SPECTROSCOPY 
4.1 Materials and Methods 
4.1.1 Endomyocardial Biopsy  
Endomyocardial biopsies are obtained from heart transplant patients during regular 
surveillance biopsy procedures. The biopsy sample is stored at -80 °C until use, at which 
time the sample is cryo-sectioned to 4 m thickness and examined by histopathology 
using haematoxylin & eosin (H&E). The remaining biopsy section adjacent to the 4 m 
slice is examined by Raman spectroscopy. The pathological results are withheld until the 
end of the study period, after which time the comparison with Raman spectra was made. 
A number of Raman spectra are obtained at different randomly selected locations within 
each biopsy specimen depending on the sample size. This procedure emulates the in vivo 
clinical environment where an optical fiber is inserted through the cardiac catheter and 
samples randomly selected endocardium sites. Patient selection criteria follow the 
guideline set by United Network for Organ Sharing (UNOS). Briefly, the patient will be 
excluded if the patient is pregnant, or if the patient develops systemic diseases that will 
affect the heart at anytime after the transplant, such as malignancy, amyloidosis, 
sarcoidosis, HIV, sepsis from infections of virus, bacteria, and fungus. The patient is also 
not eligible if refuse to sign consent for this study. A total of 17 patients are included in 
this study. 
  
4.1.2 Raman Spectroscopy Setup  
Endomyocardial biopsies are passively thawed at room temperature and put between 
two calcium fluoride slides (Buck Scientific, East Norwalk, CT) for Raman spectroscopy 
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experiment. The edges of the calcium fluoride slides are sealed by petrolatum to prevent 
the biopsy samples from dehydration. The Raman spectroscopy experiments are 
conducted using a confocal Raman microscope, equipped with a 100mW 785nm 
wavelength single-line diode laser (LabRAM HR800, HoribaJobinYvon, Edison, NJ). All 
data are acquired using a 10X objective (NA=0.25) with a spot size of 100 m at the 
sample. Shutter setting is fixed at 10 sec exposure time with 180 accumulations 
throughout the experiment. A 600 lines/mm grating is used and the range of wavenumber 
recorded is between 522 cm
-1
 and 1253 cm
-1
. The intensity of the obtained Raman spectra 
is peak-normalized at 718 cm
-1
, which is associated with membrane phospholipids and 
relatively stable. Intensity exhibit is offset vertically for display. No background 
subtraction is performed in order to preserve the integrity of the original data. The study 
was approved by the Institutional Review Board of Drexel University College of 
Medicine and all subjects gave informed consent.  
 
4.2 Results and Analysis 
To establish the validity of Raman spectroscopy in detecting cardiac allograft 
rejection, comparative studies are performed on endomyocardial biopsies using both 
Raman spectroscopy and standard histopathology. Spatially resolved Raman spectra are 
obtained from the biopsy at randomly selected locations and the result is compared with 
an adjacent tissue section stained by H&E. “Rejected” Raman spectra is defined 
quantitatively as the intensity at 758 cm
-1
 surpasses that of the adjacent Raman band at 
718 cm
-1
, i.e. when I758 > I718. Comparison is then made between the locations at which 
rejected Raman spectra are observed and the distribution of lymphocytes in the H&E 
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stained image. Figure 8 shows a typical Grade-1R (mild rejection) endomyocardial 
biopsy examined by Raman spectroscopy (a, b, c) and histopathology (d). Rejected 
Raman spectra and their corresponding positions are marked in red in Figure 8(a, b, c). 
Agreement between Raman and histopathological results are clearly observed as the 
distribution of rejected Raman spectra overlap with lymphocyte aggregation. This result 
confirms the ability of Raman spectroscopy to detect cardiac allograft rejection. 
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Figure 8. shows a typical Grade-1R (mild rejection) endomyocardial biopsy 
examined by (a, b, c) Raman spectroscopy and (d) histopathology with haematoxylin 
& eosin (H&E) stain. Raman spectra and the locations at which they are obtained 
are numbered accordingly in Figure 8(a) and (c), with rejected Raman spectra 
(I758 > I718) and their corresponding locations marked in red. Rejection-specific 
spectral regions of the 10
th
 and 11
th
 Raman spectra are shaded in Figure 8(a) and 
enlarged in Figure 8(b) for better visualization. The H&E stained picture of an 
adjacent tissue section is shown in Figure 8(c). The distribution of rejected Raman 
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spectra matches that of lymphocytes, and the distribution of normal Raman spectra 
(I758 > I718) matches that of normal cardiac muscle. Scale bars are 100 m. Adapted 
from reference 
67
. 
 
 
 
Figure 9. A Grade-1R (mild rejection) endomyocardial biopsy is examined by (a) 
histopathology with haematoxylin & eosin (H&E) stain  and (b, c, d) Raman 
spectroscopy. Raman spectra and the locations at which they are obtained are 
numbered in Figure 9(c) and (b), with rejected Raman spectra (I758 > I718) and their 
corresponding locations (Number 1~11) marked in red. Rejection-specific spectral 
regions of the 11
th
 and 12
th
 Raman spectra are shaded in Figure 9(c) and enlarged in 
Figure 9(d) for display. Locations of moderate lymphocyte infiltration and cardiac 
myocyte necrosis observed in the H&E image (a) are seen to conform with those of 
rejected Raman spectra (b, c). Scale bars are 100 m. Adapted from reference 122. 
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To evaluate the feasibility of Raman spectroscopy for clinical applications, each 
individual endomyocardial biopsy is classified by Raman spectroscopy as either normal 
or rejected according to the percentage of rejected Raman spectra found on the biopsy. 
This classification is then compared with the histopathological reading. It is found that 
Raman spectroscopy indeed consistently identifies Grade-1R biopsies by detecting the 
abnormal intensity increase at 758 cm
-1
. For 11 out of the 12 Grade-1R biopsies 
examined, rejected Raman spectra consistently account for more than 35% of the spectra 
obtained while only 1 out of 17 Grade-0 biopsies exhibits such property (Table 2). 
Results here show that increased frequency of occurrence of rejected Raman spectra 
obtained at randomly selected locations on a biopsy correlates with elevated immune 
response, suggesting that cardiac allograft rejection can be identified by the relative 
occurrence of rejection specific Raman spectra.  
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Table 2. Summary of the histopathological readings of the biopsy samples and the 
results of their Raman spectroscopy studies. A biopsy is defined as “rejected” by 
Raman spectroscopy if more than 35% of its Raman spectra are abnormal, i.e. 
I758/I718 > 1. Using this definition, eleven out of the twelve Grade-1R biopsies are 
classified as rejected by Raman spectroscopy, while only 1 out of 17 Grade-0 
biopsies display such property. Adapted from reference 
67
. 
 
Sample Grade 
Total Spectra 
number 
Abnormal 
I758/I718 > 1 
Normal 
I758/I718 ≤ 1 
Abnormal 
Percentage 
1 
Grade 0 
12 0 12 0% 
2 15 0 15 0% 
3 13 0 13 0% 
4 15 0 15 0% 
5 7 4 3 57% 
6 17 1 16 6% 
7 6 1 5 17% 
8 19 2 17 11% 
9 17 0 17 0% 
10 5 0 5 0% 
11 15 3 12 20% 
12 15 0 15 0% 
13 15 0 15 0% 
14 14 1 13 7% 
15 16 1 15 6% 
16 6 0 6 0% 
17 14 0 14 0% 
 Subtotal 221 13 208 6% 
18 
Grade 1R 
2 2 0 100% 
19 14 5 9 36% 
20 22 11 11 50% 
21 24 22 2 92% 
22 5 5 0 100% 
23 24 14 10 58% 
24 23 2 21 8% 
25 12 5 7 42% 
26 19 11 8 58% 
27 22 10 12 45% 
28 22 9 13 41% 
29 16 6 10 38% 
 Subtotal 205 102 103 50% 
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The observed Raman spectral difference between normal and rejected biopsies at 758 
cm
-1
 is a well-known characteristic of indole ring vibration
123
 and comparison with 
various indole derivatives’ Raman spectra implicates a particular indole, serotonin, as the 
underlying molecular marker instigating the observed spectral difference. The abnormal 
intensity increase at 758 cm
-1
 has been quantitatively defined above as I758 > I718, and is 
consistently observed in all of the 12 Grade-1R biopsies examined. Since this 758 cm
-1
 
Raman band is a well-known characteristic of indole ring vibration,
123
 Raman spectra of 
several naturally occurring indoles are examined for comparison with normal and 
rejected Raman spectra. Averages of 311 normal and 115 rejected Raman spectra are 
obtained, together with the Raman spectra of serotonin, tryptophan, melatonin, 5-
hydroxyindoleacetic acid, 5-hydroxytryptophan, and 5-methoxytryptophan. As seen in 
Figure 10, in addition to the 758 cm
-1
 band which is common to all indoles, rejected 
Raman spectra contain an additional band at 678 cm
-1
 which is unique to serotonin. The 
Raman spectral difference observed between rejected and normal heart biopsies is 
therefore attributed to serotonin, a known immunomodulator.
124
 By detecting the 
selective existence of indoles in rejected cardiac allografts, Raman spectroscopy’s 
molecular specific detection capability for clinical applications is demonstrated.  
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Figure 10. Rejection-specific Raman spectral features are clearly observed at 758 
cm
-1
 and 678 cm
-1
 where the average of rejected Raman spectra (1) shows elevated 
intensities when compared to averaged normal Raman spectrum (2). Spectral 
comparison with naturally occurring indoles, including serotonin (3), 5-
methoxytryptophan (4), 5-hydroxyindoleacetic acid (5), melatonin (6), 5-
hydroxytryptophan (7), and tryptophan (8) reveals that Raman bands of serotonin 
coincide with the spectral differences observed between normal and rejected heart 
biopsies. Adapted from reference 
67
. 
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Minimally invasive optical techniques capable of differentiating between diseased 
and normal tissues are attractive alternatives to invasive biopsy procedures. By probing 
the intrinsic molecular vibrations, Raman spectroscopy is capable of chemical and 
molecular specific detections without the need for exogenous labeling. In addition, no 
tissue removal or sectioning is required. The wavelengths of a typical probing laser and 
the Raman scattered light are both in the non-ionizing infrared region, further facilitating 
its use for in vivo biomedical applications. Minimally invasive optical fiber-based 
insertion devices such as catheters and endoscopes are also available.
5,125
 More recently, 
Raman spectroscopy has been used to classify regions of diseased and normal tissues,
126
 
and the underlying compositional differences can be determined given a priori 
knowledge of the tissues’ constituents, such as fat, collagen, cell nucleus, cell cytoplasm, 
and -carotene.7,8 However, wider adoption of Raman spectroscopy in clinical settings 
has yet to be seen primarily due to the lack of specific biomarkers with strong and 
characteristic Raman scattering signals. Here distinct Raman spectral features of an 
indole ring are consistently identified in rejected endomyocardial biopsies and used to 
detect cardiac allograft rejections. In addition, these Raman spectral signatures of rejected 
biopsies are attributed to a particular indole derivative, serotonin, which is known to 
mediate various immune responses.
124,127
 The detection of cardiac allograft rejection by 
Raman spectroscopy is shown to agree with histopathological results and the potential 
use of Raman spectroscopy in detecting ring-structured endogenous molecular markers 
for clinical applications is demonstrated.  
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A particular indole derivative, serotonin, is implicated here as the biomarker for 
cardiac allograft rejection. Serotonin is a well-known neurotransmitter whose immune 
modulation effects have gained increasing recognition recently.
128-130
 Serotonin is 
released by platelets at the sites of tissue injury
131
 and has been shown to regulate various 
immune responses such as delayed-type hypersensitivity,
132
 phagocytosis,
133
 and mast 
cell chemotaxis.
134
 Serotonin is also implicated in the pathogenesis of a variety of 
inflammatory disorders, such as asthma, inflammatory bowel syndrome, and chronic 
eczema. Recently serotonin has been shown to promote T-cell activation and 
proliferation,
135
 the primary immune mechanism responsible for allograft rejection.
136
 For 
cardiac allograft rejection in particular, the role of serotonin has recently been suggested 
as a serotonin receptor antagonist prolongs the life span of heart transplants in mice.
127
 
Given the diverse arrays of serotonin receptor isoforms expressed differentially by 
various immune cells,
124
 we expect serotonin to involve in a wider range of immune 
responses.
137
 Such expectation, if realized, will further broaden the clinical utility of 
Raman spectroscopy.  
 
A multivariate statistical method, principle component analysis (PCA), is employed 
here to confirm the validity of the intensity ratio test (I758 > I718) used above. PCA is an 
unsupervised statistical method typically used in spectral chemometrics. Such statistical 
methods are also useful for larger amounts of data often encountered in clinical settings. 
Here PCA is used to confirm the spectral separation observed by the intensity ratio test 
between normal and rejected Raman spectra. Comparison of PCA with intensity ratio test 
yields consistent results where separation between rejected (I758 > I718, red) and normal 
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(I758 < I718, blue) Raman spectra is clearly observed (Figure 11). In addition, PCA enables 
the visualization of data clustering and as a result will be useful for future clinical 
deployment of Raman spectroscopy. 
 
 
 
Figure 11. Multivariate statistical analysis PCA also confirms the separation of 
rejected Raman spectra from normal ones. Separation achieved by this statistical 
method is consistent with that obtained by the intensity ratio test where normal (I758 
≤ I718) and rejected (I758 > I718) Raman spectra are marked in blue and red, 
respectively. Adapted from reference 
67
. 
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The characteristic Raman band of indole rings at 758 cm
-1
, together with an adjacent 
and relatively stable membrane phospholipids band at 718 cm
-1
, permits the use of 
intensity ratio test as the quantitative measure for detecting heart transplant rejection with 
Raman spectroscopy. In addition, the consistent emergence of serotonin’s unique Raman 
band at 678 cm
-1
 in rejected biopsy specimens essentially enables direct spectral 
identification. Results obtained with this method, which utilizes characteristic Raman 
signatures of the disease biomarker serotonin, are confirmed by PCA. Note that 
serotonin’s other Raman bands at 824 cm-1 and 938 cm-1 overlap with those of collagen 
as well as other commonly seen molecules in the tissue, and as a result can not be used 
for rejection identification. Fluorescent noises existed in the Raman spectra can also 
cause variations between the classification results obtained with intensity ratio test and 
PCA. To achieve improved signal quality, we therefore intend to examine spectral 
regions with wavenumbers greater 1500 cm
-1
, where interference from fluorescence is 
expected to be minimal.  
 
Sophisticated data processing, namely background subtraction, is specifically avoided 
here in order to preserve data integrity. While commonly employed for qualitative 
display of spectra, it is well known that background subtraction causes subsequent 
statistical analysis such as PCA to fail.  It is primarily due to the artificial variance 
introduced into the spectra when one subjectively fits and removes higher-order 
polynomials as the background.
138-140
 Despite this fact, use of background subtraction 
continues to exist in clinical Raman applications where data interpretation depends on 
complicated spectral data processing. We would like to point out that, to the best of our 
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knowledge, it presents the first experimental result where differentiability between 
normal and diseased states is clearly observable in original Raman spectra without the 
need for data processing. Such observation is also verified by PCA, an objective 
multivariate statistical analysis. 
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CHAPTER 5. SERS STUDY OF INDOLIC MOLECULES ADSORBED ON GOLD 
COLLOIDS 
5.1 Materials and Methods 
Serotonin, tryptophan, melatonin, and 5-HIAA (≥98% purity) are purchased from 
Sigma-Aldrich Co. (St. Louis, MO). Gold colloids are purchased from Structure Probe, 
Inc. (West Chester, PA), with a size of 20nm, and a concentration of ~ 7.0×10
11
 per ml. 
The mixed solutions are then excited by a near infrared (NIR) integrated Raman system 
(LabRam800HR, Horiba Jobin Yvon, Edison, NJ) with 100mW 785 nm wavelength 
single-line diode laser. The exposure time is 20 seconds. 
 
Apparent enhancement factor (AEF) is calculated following the standard in the 
literature.
13
 An averaged AEF is calculated using ten Raman bands within the spectral 
range (Fig. 2). A linear regression method, nonnegative least squares (NNLS),
141
 is used 
to quantify the relative concentration of indolic molecules mixed in the gold colloidal 
solution. By fitting the SERS spectrum of the mixture as a weighted sum of those of 
individual indoles, the NNLS coefficients are proportional to the product of indole 
concentration and its AEF. 
5.2 Results and Analysis 
SERS intensities observed correlate strongly with varying pH value (Figure 12). Both 
serotonin and tryptophan are ampholytes in aqueous solutions, with serotonin having a 
hydroxyl and an amine group, and tryptophan a carboxyl and an amine group. Since the 
electrostatic status of serotonin and tryptophan changes with pH, their electrostatic 
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interaction with the negatively charged gold colloid surface also changes with the pH 
level. SERS spectra of the solutions were taken at various pH levels, all at a 
concentration of 5×10
-6
 mol/L. 
 
 
Figure 12. SERS spectra of serotonin and its solutions mixed with gold colloids (a, d) 
are shown at (1) pH=1.6, (2) pH=2.2, (3) pH=3.0, (4) pH=4.1, (5) pH=5.0, (6) pH=6.1, 
(7) pH=7.1. SERS spectra of tryptophan and its solutions mixed with gold colloids (b, 
e) are shown at (1) pH=1.6, (2) pH=2.1, (3) pH=3.0, (4) pH=4.1, (5) pH=5.0, (6) 
pH=6.0, (7) pH=7.1. (c) Averaged AEFs of serotonin (red) and tryptophan (blue) at 
various pH levels are obtained from 8 measurements and presented with their 
respective pK1. Adapted from reference 
25
. 
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The onset of SERS is observed as the pH value drops below pI and approaches pK1, 
at which levels the molecules begin to be positively charged. The electrostatic interaction 
between the negatively-charged gold colloids and the positively-charged molecules 
contributes to the SERS phenomenon. The pK1, pK2, and pI of serotonin are 4.9, 9.8, and 
7.35 respectively. For tryptophan, pK1 and pK2 are 2.38 and 9.34 respectively, and its pI 
is 5.86.
142
 Indeed as seen in Figure 12(a, b, c) SERS effects are observed at pH level 
lower than 6.1 for serotonin, and lower than 5.0 for tryptophan. As the pH value 
continues to decrease toward pK1, more amine groups are protonated and stronger SERS 
signal is observed. 
 
At pH levels below their respective pK1, serotonin and tryptophan molecules are fully 
protonated in solution and strong SERS effects are observed. As shown in Figure 12(a, c), 
serotonin’s SERS spectra become significantly stronger as the pH values approach and 
decrease beyond its pK1. Likewise for tryptophan as shown in Figure 12(b, c), strong 
SERS effects are observed at pH=1.6, 2.1 and 3.0. Additionally in Figure 12(c), one also 
observes that SERS spectral intensity continues to increase as pH level drops below pK1. 
It is likely a result of gold nanoparticles aggregating with the positively-charged 
ampholytes, forming 3D complexes.
143
 These 3D nanostructures induce greater SERS 
enhancement than 1D or 2D nanostructures.
144
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The emergence of SERS is also seen to be accompanied by color changes in the 
solution. As described above, the pH dependence of SERS is attributed to the protonation 
of ampholytes and the aggregation of gold nanoparticles. Similarly the observed color 
change at low pH values is a result of colloid aggregation. This is because the 
accumulation of gold colloids alters the surface plasmon characteristics and light 
absorption by the surface plasmon determines the color of the solution. At pH levels 
where strong SERS signals are observed, i.e. below pH 5.1 for serotonin and below pH 
3.0 for tryptophan, the solutions [Figure 12(d) and (e)] are light blue. At higher pH levels 
where SERS phenomenon disappears, the solution is pink in color. In addition, for pure 
gold colloid solutions with neither serotonin nor tryptophan present, this color change 
phenomenon was also observed although at a much lower pH level (pH = 2.0). These 
observations suggest that the existence of highly protonated molecules such as serotonin 
and tryptophan in this case facilitates gold colloid aggregation, which in turn enhances 
the SERS phenomenon. 
 
A reversible correlation in SERS intensity with respect to pH levels is also observed. 
As described above, serotonin is an ampholyte in aqueous solutions, with a hydroxyl and 
an amine group. Since the electrostatic status of serotonin changes with pH, their 
electrostatic interaction with the negatively charged gold colloid surface also changes 
with the pH level, which in turn results in changes in SERS intensity. Figure 13 shows 
SERS intensity changes as a function of serotonin solution’s pH level. SERS intensity of 
the serotonin/gold colloid solution increases as the pH level decreases from 5.0 to 1.0 by 
adding HCl. NaOH is subsequently added to the solution to raise the pH level back to 5.0. 
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At pH=1.5, 3.0 and 5.0, SERS intensity reduces back to the same level as before NaOH 
was added, which indicates that the electrostatic interaction between serotonin and gold 
colloid surface is reversible. The result demonstrated that SERS is a reliable and 
repeatable technique for the detection of serotonin. 
 
 
Figure 13. SERS intensity of serotonin is a reversible function of the pH values. The 
top panel shows the intensities at 816 cm-1 at varying pH levels. HCl was added first 
to decrease the pH values from 5 to 1 (red), and then NaOH was added to bring the 
pH values back to 1.5, 3 and 5 for comparison (blue). Corresponding spectra are 
shown in the lower panel. 
 
 
Specific Raman vibrational modes of an indole ring are examined for serotonin, 
tryptophan, melatonin and 5-HIAA (Table 3). Substantially downward band shifts are 
observed in SERS spectra of the four indolic molecules, comparing with their ordinary 
Raman spectra, which indicate the interaction between the indole ring and the gold 
colloidal surface. The two strong Raman bands at 757 and 937 cm
-1
 for serotonin are 
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assigned to the indole ring in-phase and out-of-phase breathing modes, respectively 
(Figure 14). These two bands are downward shifted to 750 and 918 cm
-1
 in SERS 
spectrum of serotonin. In addition, the band at 826 cm
-1
 in ordinary Raman spectrum of 
serotonin is attributed to indole ring NH bending, which shifts to 816 cm
-1
 in the SERS 
spectrum. Serotonin’s other indole Raman bands present these shifts as well, i.e. 460, 678, 
1133, 1235, 1433 and 1549 cm
-1
. Likewise, these clearly observable downward shifts of 
indole Raman bands happen for tryptophan, melatonin and 5-HIAA, as shown in Table 3. 
 
Table 3. Band assignments for the Raman and SERS spectra of serotonin, 
tryptophan, melatonin and 5-HIAA. Adapted from reference 
145
. 
 
 
 
Assignment
146-149
 
Serotonin Tryptophan Melatonin 5-HIAA 
Raman 
(cm
-1
) 
SERS 
(cm
-1
) 
Raman 
(cm
-1
) 
SERS 
(cm
-1
) 
Raman 
(cm
-1
) 
SERS 
(cm
-1
) 
Raman 
(cm
-1
) 
SERS 
(cm
-1
) 
Indole ring stretching 460 450 460 421 458 429 457 451 
Indole ring NH bending 678 632 575 565 663 634 679 624 
Indole ring in-phase 
breathing 
757 750 757 749 751 745 751 744 
Indole ring NH bending 826 816 877 868 819 813 841 826 
Indole ring out-of-phase 
breathing 
937 918 1010 990 922 907 924 914 
Benzene H scissoring 1133 1112 1132 1109 1133 1085 1130 1114 
Benzene H scissoring 
Pyrrole H rocking 
1235 1221 1256 1226 1235 1219 1247 1215 
Indole ring stretching 1433 1425 1430 1413 1428 1410 1432 1423 
Indole ring stretching 1549 1518 1551 1521 1549 1513 1552 1519 
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Figure 14. (a) SERS spectrum of serotonin at 5×10
-6
mol/L (1), and ordinary Raman 
spectrum at 0.1mol/L (2). (b) SERS spectrum of tryptophan at 5×10
-6
mol/L (1), and 
ordinary Raman spectrum at 5×10
-2
mol /L (2). Adapted from reference 
25
. 
 
 
 
The spectral shifts described above are consistent with previous studies in which the 
indole NH band shifts downward following the formation of a hydrogen bond.
150
 The 
indole NH group is a well-known proton donor, which tends to form hydrogen bonds 
with negatively charged gold colloids. As a result, indole rings interact strongly with 
colloidal gold, causing the indole NH band as well as other Raman bands of indole to 
shift downward. These substantial downward shifts observed in our study suggest strong 
interaction between the indole ring and the gold colloids. These observations are also 
consistent with previous SERS studies of tryptophan using positively charged silver 
colloids, where no significant Raman band shifts are recorded.
146
 The positively charged 
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silver colloidal surface prevents the formation of hydrogen bonds and as a result shuns 
interaction with the ring structure of indole. In this study, we showed that using gold 
colloids instead of silver enables one to exploit the strong Raman signals associated with 
the indole ring structure.   
 
SERS spectra are also obtained from solutions containing multiple indolic molecules, 
all at concentrations of 5×10
-6
 mol/L, and NNLS fits are performed to determine their 
relative concentration. In the first experiment, a solution containing both serotonin and 
tryptophan is examined. SERS spectrum of this mixture (line 5 in Figure 15) is fitted with 
those of serotonin (line 1 in Figure 15) and tryptophan (line 2 in Figure 15). The NNLS 
coefficients for serotonin and tryptophan are 0.730 and 0.216, respectively. Taking into 
consideration their respective averaged AEFs at 5×10
-6
mol/L, which are 4.69×10
4
 and 
1.35×10
4
 respectively, the NNLS fitting result gives a concentration ratio of serotonin to 
tryptophan at (0.730/4.69×10
4
) : (0.216/1.35×10
4
) = 1.00 : 1.03, which is in good 
agreement with the administered concentrations in the mixture. Similarly, a second 
experiment is conducted where we obtain the SERS spectrum (line 6 in Figure 15) of a 
solution containing serotonin, tryptophan, melatonin and 5-HIAA. NNLS fitting is 
performed again with SERS spectra of these four individual indoles (line 1-4 in Figure 
15). The NNLS fitted composition ratios are (0.503/4.69×10
4
) : (0.147/1.35×10
4
) : 
(0.287/2.46×10
4
) : (0.115/1.12×10
4
) = 1.00 : 1.02 : 1.09 : 0.957 for serotonin, tryptophan, 
melatonin and 5-HIAA respectively. This result is again in good agreement with 
administered concentrations of serotonin, tryptophan, melatonin and 5-HIAA. Note that 
the AEFs of melatonin and 5-HIAA are 2.46×10
4
 and 1.12×10
4
, respectively. A third and 
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a fourth experiment are performed using the same method. SERS spectra of the third 
mixture containing serotonin and 5-HIAA (line 7 in Figure 15), and the forth mixture 
containing serotonin, tryptophan and 5-HIAA (line 8 in Figure 15) are fitted using spectra 
of their respective compositions. The relative concentration ratios are (0.830/4.69×10
4
) : 
(0.183/1.12×10
4
) = 1.00 : 0.923 for serotonin and 5-HIAA in the third experiment, and 
(0.627/4.69×10
4
) : (0.181/1.35×10
4
) : (0.146/1.12×10
4
) = 1.00 : 1.00 : 0.975 for serotonin, 
tryptophan and 5-HIAA in the fourth experiment. The relative concentration ratios for 
these four mixtures are presented in Figure 15(b). These experiments demonstrate that the 
relative concentration of serotonin with respect to other closely related indoles in a mixed 
solution can be quantitatively determine from its SERS spectrum. 
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Figure 15. The SERS spectra (a) of serotonin (1), tryptophan (2), melatonin (3) and 
5-HIAA (4) are shown, all at concentration 5×10
-6
mol/L. SERS spectra of four 
different mixtures containing various indolic components, all at 5×10
-6
mol/L, are 
marked in blue, with their respective NNLS fit in red and fitting residuals in grey. 
The compositions in the four mixtures are serotonin and tryptophan (5), serotonin, 
tryptophan, melatonin and 5-HIAA (6), serotonin and 5-HIAA (7), serotonin, 
tryptophan and 5-HIAA (8), respectively. Relative concentrations of the indolic 
components in the four mixtures are normalized with respect to serotonin (b). 
Serotonin, tryptophan, melatonin and 5-HIAA are marked with circles (○, red), 
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squares (□, blue), diamonds(◊, green) and triangles(△, brown), respectively. 
Adapted from reference 
25
. 
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CHAPTER 6. CONCLUTION AND FUTURE WORK 
Unlike prior Raman clinical applications, the need for complicated data processing is 
overcome by employing the concept of a Raman biomarker, serotonin. Utilizing the 
strong and specific Raman spectral characteristics of this indole biomarker, disease 
differentiability is directly observable in the original Raman spectra. Furthermore, this 
work has demonstrated the molecular specific detection capability of Raman 
spectroscopy beyond the limitation of a set of a priori common tissue constituents. We 
anticipate this new paradigm of disease specific “Raman optical biomarker” to stimulate 
searches of other ring-structured biomolecules specific to disease models, and as a result 
open up a wider application of Raman spectroscopy in clinical settings.  
 
The direct optical detection of specific biomolecules that distinguish a diseased state 
using Raman spectroscopy demonstrates its potential for in vivo molecular diagnostics. 
Without the need for exogenous labeling, Raman spectroscopy complements 
immunohistochemical methods for it is especially sensitive to small ring-structured 
signaling molecules which are difficult to detect with conventional 
immunohistochemistry. With the demonstrated new paradigm in utilizing Raman 
spectroscopy and the advancements in biomarker discovery, Raman spectroscopy can 
potentially become a clinically viable tool for minimally invasive, molecular specific, in 
vivo diagnostics. 
 
As the roles and functions of the 14 serotonin receptor subtypes in the immune 
system continue to be discovered and defined,
137,151,152
 definitive detection techniques for 
their common signaling molecule, serotonin, are critically needed. In addition, such 
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techniques need to be able to distinguish serotonin from its closely related precursors and 
metabolites. Here we demonstrated the capability of SERS for such a task and we 
envision increasing SERS applications in the study of immune responses.  
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CHAPTER 7. CONTRIBUTION 
This work is the first approach to use Raman spectroscopy to detect heart transplant 
rejection. Allograft transplantation is the last-resort therapy for patients with failed organs. 
Its efficacy relies on the successful management of the recipient's immune responses. The 
current standard surveillance method using endomyocardial biopsy is subject to sampling 
errors, since only 4 samples are examined each time, the rejected site may be missed. It is 
invasive and causes morbidity and rarely mortality, because of the open wounds left in 
the heart. And it is subjective because the severity is determined by a pathologist. Here 
the capability of Raman spectroscopy to detect cardiac rejection is demonstrated in this 
work. To our best knowledge, this is the first approach to detect cardiac rejection using 
Raman spectroscopy. 
 
An optical biomarker was discovered and used for the effective detection by Raman 
spectroscopy. Unlike prior Raman clinical applications, the need for complicated data 
processing is overcome by employing the concept of a Raman biomarker, serotonin. 
Utilizing the strong and specific Raman spectral characteristics of this indole biomarker, 
disease differentiability is directly observable in the original Raman spectra. Furthermore, 
this work has demonstrated the molecular specific detection capability of Raman 
spectroscopy beyond the limitation of a set of a priori common tissue constituents. We 
anticipate this new paradigm of disease specific “Raman optical biomarker” to stimulate 
searches of other ring-structured biomolecules specific to disease models, and as a result 
open up a wider application of Raman spectroscopy in clinical settings. 
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It is the first SERS analysis on serotonin and its related molecules including 
melatonin and 5-HIAA to my best knowledge. Electrostatic interaction between the 
positively charged amine on the serotonergic molecules and the negatively charged gold 
colloidal surface plays a significant role in Raman surface enhancement phenomenon. 
The detectable concentration is as low as 1×10
-7
 mol/L for serotonin and 3×10
-7
 mol/L 
for tryptophan. The regular Raman peaks and SERS peaks in spectra of serotonin, 
tryptophan, melatonin and 5-HIAA are also assigned in this work  
 
This work successfully qualifies the relative concentrations of indole molecules in 
mixed solution. It is shown that the relative concentration of serotonin, tryptophan, 
melatonin and 5-HIAA in mixed solutions can be quantitatively determine from a SERS 
spectrum, demonstrating the potential use of SERS for in vitro diagnostics. Further 
optimization of the AEF is needed to allow in vivo diagnostics under physiological 
conditions. 
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